Norges Bank Intra Cellular Therapies, Inc. Transaction History

Norges Bank

$655 Billion
Q2 2024

A detailed history of Norges Bank transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Norges Bank holds 1,943,730 shares of ITCI stock, worth $149 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,943,730

Holding current value

$149 Million

% of portfolio

0.02%

47 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $126 Million - $155 Million	1,943,730 New	1,943,730 $133 Million
Q4 2023 Feb 09, 2024	BUY	$46.37 - $73.65 $55.5 Million - $88.2 Million	1,197,203 New	1,197,203 $85.7 Million
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $45 Million - $55.3 Million	-862,933 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$54.67 - $66.44 $62.7 Million - $76.2 Million	-1,147,146 Reduced 59.02%	796,584 $50.4 Million
Q2 2023 Aug 14, 2023	SELL	$54.67 - $66.44 $43.7 Million - $53.2 Million	-800,230 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$43.8 - $56.99 $41.9 Million - $54.5 Million	957,181 New	957,181 $51.8 Million
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $45.9 Million - $56.7 Million	1,041,874 New	1,041,874 $55.1 Million
Q3 2022 Nov 13, 2023	BUY	$42.7 - $59.99 $36.8 Million - $51.8 Million	862,933 New	862,933 $40.2 Million
Q2 2022 Aug 14, 2023	BUY	$43.0 - $65.64 $34.4 Million - $52.5 Million	800,230 New	800,230 $45.7 Million
Q1 2022 May 12, 2023	SELL	$38.74 - $62.09 $15.6 Million - $25.1 Million	-403,932 Reduced 38.77%	637,942 $39 Million
Q1 2022 May 09, 2022	SELL	$38.74 - $62.09 $22.6 Million - $36.2 Million	-583,207 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$35.2 - $53.42 $20.5 Million - $31.2 Million	583,207 New	583,207 $30.5 Million
Q3 2021 Nov 14, 2022	BUY	$28.72 - $42.49 $10.3 Million - $15.2 Million	357,588 New	357,588 $13.3 Million
Q3 2021 Nov 05, 2021	SELL	$28.72 - $42.49 $12.3 Million - $18.2 Million	-428,485 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$29.3 - $44.5 $12.6 Million - $19.1 Million	428,485 New	428,485 $17.5 Million
Q2 2021 Aug 10, 2021	SELL	$29.3 - $44.5 $8.23 Million - $12.5 Million	-281,035 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$30.8 - $39.51 $8.66 Million - $11.1 Million	281,035 New	281,035 $9.54 Million
Q1 2021 May 07, 2021	SELL	$30.8 - $39.51 $16.2 Million - $20.8 Million	-527,281 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$23.34 - $32.22 $12.3 Million - $17 Million	527,281 New	527,281 $16.8 Million
Q4 2020 Feb 10, 2021	SELL	$23.34 - $32.22 $8.18 Million - $11.3 Million	-350,623 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$17.61 - $31.86 $6.17 Million - $11.2 Million	350,623 New	350,623 $9 Million
Q3 2020 Nov 10, 2020	SELL	$17.61 - $31.86 $10.9 Million - $19.7 Million	-617,235 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$14.35 - $26.64 $8.86 Million - $16.4 Million	617,235 New	617,235 $15.8 Million
Q2 2020 Aug 07, 2020	SELL	$14.35 - $26.64 $8.57 Million - $15.9 Million	-597,440 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$12.31 - $33.12 $7.35 Million - $19.8 Million	597,440 New	597,440 $9.18 Million
Q1 2020 May 08, 2020	SELL	$12.31 - $33.12 $2.76 Million - $7.41 Million	-223,810 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$7.26 - $38.49 $1.62 Million - $8.61 Million	223,810 New	223,810 $7.68 Million
Q4 2019 Feb 12, 2020	SELL	$7.26 - $38.49 $2.06 Million - $10.9 Million	-283,505 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$7.47 - $14.03 $2.12 Million - $3.98 Million	283,505 New	283,505 $2.12 Million
Q3 2019 Nov 08, 2019	SELL	$7.47 - $14.03 $2.47 Million - $4.63 Million	-330,070 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$10.65 - $14.29 $3.52 Million - $4.72 Million	330,070 New	330,070 $4.28 Million
Q2 2019 Aug 09, 2019	SELL	$10.65 - $14.29 $3.52 Million - $4.72 Million	-330,070 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$10.36 - $20.96 $3.42 Million - $6.92 Million	330,070 New	330,070 $3.76 Million
Q4 2018 Feb 08, 2019	SELL	$10.36 - $20.96 $3.42 Million - $6.92 Million	-330,070 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$17.77 - $22.9 $5.87 Million - $7.56 Million	330,070 New	330,070 $7.16 Million
Q3 2018 Nov 09, 2018	SELL	$17.77 - $22.9 $5.87 Million - $7.56 Million	-330,070 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$17.33 - $23.4 $5.72 Million - $7.72 Million	330,070 New	330,070 $5.83 Million
Q2 2018 Jul 23, 2018	SELL	$17.33 - $23.4 $5.19 Million - $7 Million	-299,320 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$15.16 - $25.49 $4.54 Million - $7.63 Million	299,320 New	299,320 $6.3 Million
Q1 2018 May 09, 2018	SELL	$15.16 - $25.49 $4.23 Million - $7.11 Million	-279,070 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$14.27 - $16.79 $3.98 Million - $4.69 Million	279,070 New	279,070 $4.04 Million
Q4 2017 Feb 09, 2018	SELL	$14.27 - $16.79 $3.98 Million - $4.69 Million	-279,070 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$10.77 - $22.1 $3.01 Million - $6.17 Million	279,070 New	279,070 $4.4 Million
Q3 2017 Nov 07, 2017	SELL	$10.77 - $22.1 $1.82 Million - $3.74 Million	-169,070 Closed	0 $0
Q2 2017 Jul 24, 2018	SELL	N/A	-104,284 Reduced 38.15%	169,070 $2.1 Million
Q1 2017 May 11, 2018	SELL	N/A	-7,496 Reduced 2.67%	273,354 $4.44 Million
Q3 2016 Nov 13, 2017	BUY	N/A	280,850	280,850 $0

Others Institutions Holding ITCI

# of Institutions

398

Shares Held

87.5M

Call Options Held

309K

Put Options Held

302K

Vanguard Group Inc Valley Forge, PA

9.61M
Shares

$737 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$485 Million
0.01% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.72M
Shares

$285 Million
1.37% of portfolio
Jpmorgan Chase & CO New York, NY

3.44M
Shares

$264 Million
0.02% of portfolio
Avoro Capital Advisors LLC New York, NY

3M
Shares

$230 Million
2.8% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.25B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account